[Autologous blood donation and isovolemic hemodilution--indications and practical implementation]
- PMID: 8142735
[Autologous blood donation and isovolemic hemodilution--indications and practical implementation]
Abstract
Objective: The state of the art of autologous blood transfusion is described with special emphasis on safety aspects, indications and medicolegal implications.
Data sources and selection criteria: Literature was retrieved using the MEDLINE literature database. Medical and legal expert opinions on autologous blood transfusion programmes are presented as well as the actual German jurisdiction. Guidelines for autologous predeposit and haemodilution used in the University of Münster are described.
Results: In the past decade all forms of autologous transfusions gained increasing influence in haemotherapy due to the ongoing discussion on the safety of blood products. The German Federal Court has demanded that whenever homologous perioperative transfusion is considered likely, patients have to be offered autologous predeposit. Legal conditions for autologous programmes directed by anaesthetists not specialised in transfusion medicine are described. Whole-blood predeposit should be limited to two autologous units. In cases with minor blood loss, isovolaemic haemodilution may be performed instead of autologous predeposit. However, autologous transfusions have their specific risks that are either related to the patient or to the procedure of autologous predeposit, e.g., clerical error, contamination of blood products and technical faults. Standard procedures of the University of Münster to ensure low-risk autologous transfusion are presented. They consist in adequate handling and proper identification, testing of donor for virus infection markers, bacterial culture from blood products and a list of contraindications: anaemia, unstable angina, myocardial infarction within 3 months, decompensated heart insufficiency, aortic valve stenosis with angina, and cases with infection and fever.
Conclusion: The risks related with autologous transfusion should be lower compared to homologous transfusions. Well-defined standards concerning indications and techniques are required to reach this goal.
Similar articles
-
[Benefits and risks of autologous blood donation].Infusionsther Transfusionsmed. 1994 Aug;21 Suppl 1:64-8. Infusionsther Transfusionsmed. 1994. PMID: 8000256 Review. German.
-
[Current legal questions in relation to autologous blood transfusion and legally controlled blood donation in Germany].Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:6-11. Infusionsther Transfusionsmed. 1994. PMID: 7841782 Review. German.
-
The impact of pre-donated autologous blood and intra-operative isovolaemic haemodilution on the outcome of transfusion in patients undergoing radical retropubic prostatectomy.Br J Urol. 1996 Jun;77(6):856-60. Br J Urol. 1996. PMID: 8705221
-
[The present possibilities for routine use of blood-saving measures from the anesthesiologic point of view--theoretical bases and clinical practice. III. Autologous blood donation, autologous donation criteria and organizational measures].Anaesthesiol Reanim. 1994;19 Suppl:18-24. Anaesthesiol Reanim. 1994. PMID: 8148014 Review. German.
-
[A comparison of autologous transfusion procedures in hip surgery].Anaesthesist. 1991 Apr;40(4):205-13. Anaesthesist. 1991. PMID: 2058822 Clinical Trial. German.
Cited by
-
Comparative changes of pre-operative autologous transfusions and peri-operative cell salvage in the United States.Transfusion. 2020 Oct;60(10):2260-2271. doi: 10.1111/trf.15949. Epub 2020 Aug 31. Transfusion. 2020. PMID: 32869327 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous